Skip to Main Content

Paper Details

A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE).
Mol Cancer Ther
14
2023
BRCA2, Bone Metastases, CDK12, HRR, HRR gene, Men, Metastatic Castration-Resistant Prostate Cancer, Olaparib, PARP, PSA, Radium-, alkaline phosphatase, androgen, androgen receptor, anemia, bone metastases, cytopenias, docetaxel, fatigue, homologous recombination repair, homologous recombination repair (HRR) gene, mCRPC, metastatic castration-resistant prostate cancer, nausea, olaparib, patients, radium-223
Author NameAffiliation
Eliezer M Van AllenDana-Farber Cancer Institute
Eliezer M Van AllenDana-Farber Cancer Institute
  • 1 - 2

Datasets

Release 1.2